Company news

Bio-works Technologies Ab (NGM:BIOWKS) news

Bio-works Technologies Ab news releases on 6ix. Latest, Aug 18, 2026: Bio-Works Technologies AB appoints Eva Lindskog as new CEO

View Bio-works Technologies Ab →

Press releases & updates

Bio-Works Technologies AB appoints Eva Lindskog as new CEO

August 18, 2026

Bio-Works Technologies: Bio-Works Receives Order for 22,6 MSEK from Returning Customer

July 17, 2026

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 7 of 11

July 15, 2026

Bio-Works Technologies: Bio-Works Receives Order for 8,9 MSEK from Returning Customer

July 6, 2026

Today is the first day of the seventh exercise period for Bio-Works Technologies AB's warrants of series TO 2

July 1, 2026

Bio-Works Technologies: Bio-Works receives order for WorkBeads 40S from contract manufacturer in Europe

April 29, 2026

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 6 of 11

April 17, 2026

Today is the first day of the sixth exercise period for Bio-Works Technologies AB's warrants of series TO 2

April 1, 2026

Bio-Works Technologies AB - Business Update first quarter 2026

April 1, 2026

Bio-Works Technologies AB publishes Business Update ahead of next value creation phase

March 6, 2026

Bio-Works Technologies: Bio-Works Receives Order from Returning Customer

February 17, 2026

Bio-Works Technologies AB announces outcome from exercise of warrants of series TO 2. Exercise period 5 of 11

January 19, 2026

Today is the first day of the fifth exercise period for Bio-Works Technologies AB's warrants of series TO 2

January 2, 2026

Bio-Works Receives Two WorkBeads 100S and 100Q Orders Worth SEK 4 Million

December 29, 2025

Bio-Works Technologies AB Annual General Meeting to be held on Thursday 4 of June 2026

December 15, 2025

Bio-Works Technologies: Bio-Works two largest shareholders, members of the board and the CEO have all exercised all their Warrants TO2

October 21, 2025

Bio-Works two largest shareholders, members of the board and the CEO have all exercised all their Warrants TO2

October 21, 2025